Skip to main content Skip to main menu
UF Health University of Florida
Division of Pediatric Nephrology Department of Pediatrics in the College of Medicine
Lawrence R Shoemaker

Lawrence R Shoemaker, M.D.

Clinical Associate Professor And Chief

Department: MD-PEDS-NEPHROLOGY
Business Phone: (352) 273-9180
Business Email: lrshoe01@peds.ufl.edu

On This Page

About Lawrence R Shoemaker

Dr. Shoemaker is an Associate Professor and Chief of Pediatric Nephrology. He is also the director of the UF Pediatric Dialysis Unit. His clinical interests include acute and chronic renal replacement therapy, fluid and electrolyte disorders and genetic kidney disease.

Accomplishments

  1. Celebrating Better Service Award

    Kosair Children’s Hospital

  2. Physician of the Quarter

    Kosair Children’s Hospital

  3. Top 5 Clinical Teacher of the Year

    University of Louisville

  4. Top 5 Clinical Teacher of the Year

    University of Louisville

  5. Top 5 Clinical Teacher of the Year

    University of Louisville

Teaching Profile

Courses Taught

  1. MDC7400 – Pediatric Clerkship

    College of Medicine

Board Certifications

  • Pediatric Nephrology
    American Board of Pediatrics
  • Pediatrics
    American Board of Pediatrics

Clinical Profile

Specialties

  • Pediatric Nephrology
  • Pediatrics

Areas of Interest

  • Chronic Kidney Disease
  • Fluid Imbalance
  • Renal

Research Profile

Areas of Interest

  • Mathematical modeling of dialysis adequacy
  • Mechanisms of acute kidney injury

Publications

Academic Articles

Grants

  1. CMS Comprehensive Children’s Kidney Failure Center – CMCAZ FY25-28

    Active

    Role:
    Principal Investigator
    Funding:
    FL DEPT OF HLTH CHILDRENS MED SERVS

  2. 214 CTOA: Shoemaker

    Active

    Role:
    Principal Investigator
    Funding:
    UNIV OF FLORIDA

  3. AN OPEN-LABEL, NONRANDOMIZED, MULTICENTER EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY AND EFFICACY OF PEGCETACOPLAN IN PARTICIPANTS WITH C3 GLOMERULOPATHY OR IMMUNE-COMPLEX MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS

    Active

    Role:
    Principal Investigator
    Funding:
    APELLIS PHARMACEUTICALS

  4. CMS Comprehensive Children’s Kidney Failure Center – COQVW Renewal for FY22-25

    Role:
    Principal Investigator
    Funding:
    FL DEPT OF HLTH CHILDRENS MED SERVS via US DEPT OF HLTH AND HUMAN SER

  5. A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLINDED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PEGCETACOPLAN IN PATIENTS WITH C3 GLOMERULOPATHY OR IMMUNE-COMPLEX MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS

    Active

    Role:
    Principal Investigator
    Funding:
    WORLDWIDE CLINICAL TRIALS via APELLIS PHARMACEUTICALS

  6. CMS Comprehensive Children’s Kidney Failure Center through FY2022

    Role:
    Principal Investigator
    Funding:
    FL DEPT OF HLTH CHILDRENS MED SERVS via US HLTH RESOURCES AND SERV ADMN

  7. CMS Comprehensive children kidney failure center

    Role:
    Principal Investigator
    Funding:
    FL DEPT OF HLTH CHILDRENS MED SERVS

Contact Details

Phones:
Business:
(352) 273-9180
Emails:
Business:
lrshoe01@peds.ufl.edu
Addresses:
Business Mailing:
PO Box 100296
 GAINESVILLE FL 32610
Business Street:
Department of Pediatrics
Division of Pediatric Nephrology
1600 SW Archer Road
 Gainesville FL 32607